APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glutamate Carboxypeptidase 2

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glutamate Carboxypeptidase 2 Industry Growth and Trends Forecast to 2032

19 December 202573 pages

Choose your research edition.

Industry ResearchGlutamate Carboxypeptidase 2 Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Glutamate Carboxypeptidase 2 Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Glutamate Carboxypeptidase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glutamate Carboxypeptidase 2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Glutamate Carboxypeptidase 2 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Glutamate Carboxypeptidase 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glutamate Carboxypeptidase 2 include Eisai Co Ltd, Inovio Pharmaceuticals Inc, Crescendo Biologics Ltd and Cerecor Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glutamate Carboxypeptidase 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glutamate Carboxypeptidase 2 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glutamate Carboxypeptidase 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glutamate Carboxypeptidase 2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glutamate Carboxypeptidase 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glutamate Carboxypeptidase 2 Market by Company

Eisai Co Ltd

Inovio Pharmaceuticals Inc

Crescendo Biologics Ltd

Cerecor Inc

Glutamate Carboxypeptidase 2 Segment by Type

INO-5150

E-2072

Others

Glutamate Carboxypeptidase 2 Segment by Application

Glioblastoma Multiforme

Congnitive Impairment

Prostate Cancer

Neuropathic Pain

Others

Glutamate Carboxypeptidase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Carboxypeptidase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glutamate Carboxypeptidase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Carboxypeptidase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glutamate Carboxypeptidase 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glutamate Carboxypeptidase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of INO-5150 Table 2. Major Company of E-2072 Table 3. Major Company of Others Table 4. Global Glutamate Carboxypeptidase 2 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (K Units) Table 6. Global Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type (2021-2026) Table 7. Global Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (US$ Million) Table 8. Global Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type (2021-2026) Table 9. Global Glutamate Carboxypeptidase 2 Price by Type (2021-2026) & (US$/Unit) Table 10. Global Glutamate Carboxypeptidase 2 Sales by Type (2027-2032) & (K Units) Table 11. Global Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type (2027-2032) Table 12. Global Glutamate Carboxypeptidase 2 Sales by Type (2027-2032) & (US$ Million) Table 13. Global Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type (2027-2032) Table 14. Global Glutamate Carboxypeptidase 2 Price by Type (2027-2032) & (US$/Unit) Table 15. North America Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (K Units) Table 16. North America Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (K Units) Table 18. Europe Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (K Units) Table 22. Latin America Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Type (2021-2026) & (US$ Million) Table 25. Glutamate Carboxypeptidase 2 Industry Trends Table 26. Glutamate Carboxypeptidase 2 Industry Drivers Table 27. Glutamate Carboxypeptidase 2 Industry Opportunities and Challenges Table 28. Glutamate Carboxypeptidase 2 Industry Restraints Table 29. Global Glutamate Carboxypeptidase 2 Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Glutamate Carboxypeptidase 2 Revenue Market Share by Company (2021-2026) Table 31. Global Glutamate Carboxypeptidase 2 Sales by Company (2021-2026) & (K Units) Table 32. Global Glutamate Carboxypeptidase 2 Sales Share by Company (2021-2026) Table 33. Global Glutamate Carboxypeptidase 2 Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Glutamate Carboxypeptidase 2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Glutamate Carboxypeptidase 2 Major Company Production Sites and Headquarters Table 36. Global Glutamate Carboxypeptidase 2 Company, Product Type & Application Table 37. Global Glutamate Carboxypeptidase 2 Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Glutamate Carboxypeptidase 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Glutamate Carboxypeptidase 2 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Glutamate Carboxypeptidase 2 Sales by Region (2021-2026) & (K Units) Table 42. Global Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Region (2021-2026) Table 43. Global Glutamate Carboxypeptidase 2 Sales by Region (2021-2026) & (US$ Million) Table 44. Global Glutamate Carboxypeptidase 2 Sales Market Share in Value by Region (2021-2026) Table 45. Global Glutamate Carboxypeptidase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Glutamate Carboxypeptidase 2 Sales by Region (2027-2032) & (K Units) Table 47. Global Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Region (2027-2032) Table 48. Global Glutamate Carboxypeptidase 2 Sales by Region (2027-2032) & (US$ Million) Table 49. Global Glutamate Carboxypeptidase 2 Sales Market Share in Value by Region (2027-2032) Table 50. Global Glutamate Carboxypeptidase 2 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Glutamate Carboxypeptidase 2 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (K Units) Table 53. Global Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application (2021-2026) Table 54. Global Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (US$ Million) Table 55. Global Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application (2021-2026) Table 56. Global Glutamate Carboxypeptidase 2 Price by Application (2021-2026) & (US$/Unit) Table 57. Global Glutamate Carboxypeptidase 2 Sales by Application (2027-2032) & (K Units) Table 58. Global Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application (2027-2032) Table 59. Global Glutamate Carboxypeptidase 2 Sales by Application (2027-2032) & (US$ Million) Table 60. Global Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application (2027-2032) Table 61. Global Glutamate Carboxypeptidase 2 Price by Application (2027-2032) & (US$/Unit) Table 62. North America Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (K Units) Table 63. North America Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (K Units) Table 65. Europe Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (K Units) Table 69. Latin America Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Application (2021-2026) & (US$ Million) Table 72. Eisai Co Ltd Company Information Table 73. Eisai Co Ltd Business Overview Table 74. Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolio Table 76. Eisai Co Ltd Recent Development Table 77. Inovio Pharmaceuticals Inc Company Information Table 78. Inovio Pharmaceuticals Inc Business Overview Table 79. Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolio Table 81. Inovio Pharmaceuticals Inc Recent Development Table 82. Crescendo Biologics Ltd Company Information Table 83. Crescendo Biologics Ltd Business Overview Table 84. Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolio Table 86. Crescendo Biologics Ltd Recent Development Table 87. Cerecor Inc Company Information Table 88. Cerecor Inc Business Overview Table 89. Cerecor Inc Glutamate Carboxypeptidase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolio Table 91. Cerecor Inc Recent Development Table 92. North America Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Glutamate Carboxypeptidase 2 Sales by Country (2021-2026) & (K Units) Table 94. North America Glutamate Carboxypeptidase 2 Sales Market Share by Country (2021-2026) Table 95. North America Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Country (2027-2032) Table 97. North America Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Glutamate Carboxypeptidase 2 Market Share by Country (2021-2026) Table 100. North America Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Glutamate Carboxypeptidase 2 Market Share Forecast by Country (2027-2032) Table 102. Europe Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Glutamate Carboxypeptidase 2 Sales by Country (2021-2026) & (K Units) Table 104. Europe Glutamate Carboxypeptidase 2 Sales Market Share by Country (2021-2026) Table 105. Europe Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Glutamate Carboxypeptidase 2 Market Share by Country (2021-2026) Table 110. Europe Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Glutamate Carboxypeptidase 2 Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Glutamate Carboxypeptidase 2 Market Share by Country (2021-2026) Table 120. Asia-Pacific Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Glutamate Carboxypeptidase 2 Market Share Forecast by Country (2027-2032) Table 122. Latin America Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Glutamate Carboxypeptidase 2 Sales by Country (2021-2026) & (K Units) Table 124. Latin America Glutamate Carboxypeptidase 2 Sales Market Share by Country (2021-2026) Table 125. Latin America Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Glutamate Carboxypeptidase 2 Market Share by Country (2021-2026) Table 130. Latin America Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Glutamate Carboxypeptidase 2 Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Glutamate Carboxypeptidase 2 Market Share by Country (2021-2026) Table 140. Middle East and Africa Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Glutamate Carboxypeptidase 2 Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Glutamate Carboxypeptidase 2 Distributors List Table 145. Glutamate Carboxypeptidase 2 Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Glutamate Carboxypeptidase 2 Image Figure 2. Global Glutamate Carboxypeptidase 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glutamate Carboxypeptidase 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Glutamate Carboxypeptidase 2 Sales (2021-2032) & (K Units) Figure 5. INO-5150 Image Figure 6. Global INO-5150 Sales YoY Growth (2021-2032) & (K Units) Figure 7. E-2072 Image Figure 8. Global E-2072 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Glutamate Carboxypeptidase 2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Glutamate Carboxypeptidase 2 Market Share by Type 2025 VS 2032 Figure 13. North America Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type in 2025 Figure 14. North America Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type in 2025 Figure 15. Europe Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type in 2025 Figure 16. Europe Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type in 2025 Figure 19. Latin America Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Glutamate Carboxypeptidase 2 Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Glioblastoma Multiforme Image Figure 26. Global Glioblastoma Multiforme Sales YoY Growth (2021-2032) & (K Units) Figure 27. Congnitive Impairment Image Figure 28. Global Congnitive Impairment Sales YoY Growth (2021-2032) & (K Units) Figure 29. Prostate Cancer Image Figure 30. Global Prostate Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Neuropathic Pain Image Figure 32. Global Neuropathic Pain Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Glutamate Carboxypeptidase 2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Glutamate Carboxypeptidase 2 Market Share by Application 2025 VS 2032 Figure 37. North America Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application in 2025 Figure 38. North America Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application in 2025 Figure 39. Europe Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Market Share in Value by Application in 2025 Figure 47. North America Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Glutamate Carboxypeptidase 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Glutamate Carboxypeptidase 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Glutamate Carboxypeptidase 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Glutamate Carboxypeptidase 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Glutamate Carboxypeptidase 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Glutamate Carboxypeptidase 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Glutamate Carboxypeptidase 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Glutamate Carboxypeptidase 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Glutamate Carboxypeptidase 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Glutamate Carboxypeptidase 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Glutamate Carboxypeptidase 2 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Glutamate Carboxypeptidase 2 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • INO-5150
  • E-2072
  • Others
Applications
  • Glioblastoma Multiforme
  • Congnitive Impairment
  • Prostate Cancer
  • Neuropathic Pain
  • Others
Companies covered
  • Eisai Co Ltd
  • Inovio Pharmaceuticals Inc
  • Crescendo Biologics Ltd
  • Cerecor Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glutamate Carboxypeptidase 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glutamate Carboxypeptidase 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glutamate Carboxypeptidase 2 Market by Type
  6. 1.3.1 INO-5150
  7. 1.3.2 E-2072
  8. 1.3.3 Others
  9. 1.4 Global Glutamate Carboxypeptidase 2 Market Size by Type
  10. 1.4.1 Global Glutamate Carboxypeptidase 2 Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Glutamate Carboxypeptidase 2 Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Glutamate Carboxypeptidase 2 Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Glutamate Carboxypeptidase 2 Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Glutamate Carboxypeptidase 2 Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Glutamate Carboxypeptidase 2 Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Glutamate Carboxypeptidase 2 Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Glutamate Carboxypeptidase 2 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glutamate Carboxypeptidase 2 Industry Trends
  2. 2.2 Glutamate Carboxypeptidase 2 Industry Drivers
  3. 2.3 Glutamate Carboxypeptidase 2 Industry Opportunities and Challenges
  4. 2.4 Glutamate Carboxypeptidase 2 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glutamate Carboxypeptidase 2 Revenue (2021-2026)
  2. 3.2 Global Top Players by Glutamate Carboxypeptidase 2 Sales (2021-2026)
  3. 3.3 Global Top Players by Glutamate Carboxypeptidase 2 Price (2021-2026)
  4. 3.4 Global Glutamate Carboxypeptidase 2 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glutamate Carboxypeptidase 2 Major Company Production Sites & Headquarters
  6. 3.6 Global Glutamate Carboxypeptidase 2 Company, Product Type & Application
  7. 3.7 Global Glutamate Carboxypeptidase 2 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glutamate Carboxypeptidase 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glutamate Carboxypeptidase 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glutamate Carboxypeptidase 2 Tier 1, Tier 2, and Tier 3
4 Glutamate Carboxypeptidase 2 Regional Status and Outlook
  1. 4.1 Global Glutamate Carboxypeptidase 2 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glutamate Carboxypeptidase 2 Historic Market Size by Region
  3. 4.2.1 Global Glutamate Carboxypeptidase 2 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glutamate Carboxypeptidase 2 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glutamate Carboxypeptidase 2 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glutamate Carboxypeptidase 2 Forecasted Market Size by Region
  7. 4.3.1 Global Glutamate Carboxypeptidase 2 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glutamate Carboxypeptidase 2 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glutamate Carboxypeptidase 2 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glutamate Carboxypeptidase 2 by Application
  1. 5.1 Glutamate Carboxypeptidase 2 Market by Application
  2. 5.1.1 Glioblastoma Multiforme
  3. 5.1.2 Congnitive Impairment
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Neuropathic Pain
  6. 5.1.5 Others
  7. 5.2 Global Glutamate Carboxypeptidase 2 Market Size by Application
  8. 5.2.1 Global Glutamate Carboxypeptidase 2 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glutamate Carboxypeptidase 2 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glutamate Carboxypeptidase 2 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glutamate Carboxypeptidase 2 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glutamate Carboxypeptidase 2 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glutamate Carboxypeptidase 2 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glutamate Carboxypeptidase 2 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glutamate Carboxypeptidase 2 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai Co Ltd
  2. 6.1.1 Eisai Co Ltd Company Information
  3. 6.1.2 Eisai Co Ltd Business Overview
  4. 6.1.3 Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolio
  6. 6.1.5 Eisai Co Ltd Recent Developments
  7. 6.2 Inovio Pharmaceuticals Inc
  8. 6.2.1 Inovio Pharmaceuticals Inc Company Information
  9. 6.2.2 Inovio Pharmaceuticals Inc Business Overview
  10. 6.2.3 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolio
  12. 6.2.5 Inovio Pharmaceuticals Inc Recent Developments
  13. 6.3 Crescendo Biologics Ltd
  14. 6.3.1 Crescendo Biologics Ltd Company Information
  15. 6.3.2 Crescendo Biologics Ltd Business Overview
  16. 6.3.3 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolio
  18. 6.3.5 Crescendo Biologics Ltd Recent Developments
  19. 6.4 Cerecor Inc
  20. 6.4.1 Cerecor Inc Company Information
  21. 6.4.2 Cerecor Inc Business Overview
  22. 6.4.3 Cerecor Inc Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolio
  24. 6.4.5 Cerecor Inc Recent Developments
7 North America by Country
  1. 7.1 North America Glutamate Carboxypeptidase 2 Sales by Country
  2. 7.1.1 North America Glutamate Carboxypeptidase 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glutamate Carboxypeptidase 2 Sales by Country (2021-2026)
  4. 7.1.3 North America Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glutamate Carboxypeptidase 2 Market Size by Country
  6. 7.2.1 North America Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026)
  8. 7.2.3 North America Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glutamate Carboxypeptidase 2 Sales by Country
  2. 8.1.1 Europe Glutamate Carboxypeptidase 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glutamate Carboxypeptidase 2 Sales by Country (2021-2026)
  4. 8.1.3 Europe Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glutamate Carboxypeptidase 2 Market Size by Country
  6. 8.2.1 Europe Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Country
  2. 9.1.1 Asia-Pacific Glutamate Carboxypeptidase 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glutamate Carboxypeptidase 2 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glutamate Carboxypeptidase 2 Market Size by Country
  6. 9.2.1 Asia-Pacific Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glutamate Carboxypeptidase 2 Sales by Country
  2. 10.1.1 South America Glutamate Carboxypeptidase 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glutamate Carboxypeptidase 2 Sales by Country (2021-2026)
  4. 10.1.3 South America Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glutamate Carboxypeptidase 2 Market Size by Country
  6. 10.2.1 South America Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026)
  8. 10.2.3 South America Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Country
  2. 11.1.1 Middle East and Africa Glutamate Carboxypeptidase 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glutamate Carboxypeptidase 2 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glutamate Carboxypeptidase 2 Market Size by Country
  6. 11.2.1 Middle East and Africa Glutamate Carboxypeptidase 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glutamate Carboxypeptidase 2 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glutamate Carboxypeptidase 2 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glutamate Carboxypeptidase 2 Value Chain Analysis
  2. 12.1.1 Glutamate Carboxypeptidase 2 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glutamate Carboxypeptidase 2 Production Mode & Process
  7. 12.2 Glutamate Carboxypeptidase 2 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glutamate Carboxypeptidase 2 Distributors
  10. 12.2.3 Glutamate Carboxypeptidase 2 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst